Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01645241

Enrollment

Registered

2012-07-20

Start date

2012-07-31

Completion date

2013-12-31

Last updated

2014-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility Preservation, INFERTILITY, Oocyte Donation, Ovulation Induction, Vitrification

Keywords

Ovarian stimulation, Luteal phase, Egg donors, Fertility preservation

Brief summary

The purpose of this study is to evaluate the clinical pregnancy rate per embryo transfer in oocytes recipients obtained after ovarian stimulation during the luteal phase of oocytes donors . This study will be performed in egg recipients and donors but this type of treatment is meant to be implemented in fertility preservation patients

Interventions

DRUGgonadotropins plus GnRH antagonists

DRUGganirelix

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 35 Years

Healthy volunteers

Yes

Inclusion criteria

* premenopausal women, 18-35 years old, FSH levels \< 10 mIU/ml; AFC\> 10 * regular cycles * BMI \< 28 * signed informed consent Recipients: * Infertile women eligible for oocytes donation * BMI \< 35 * Signed informed consent form

Exclusion criteria

-Polycystic ovarian syndrome, gonadotropins allergy Recipients: * Women eligible for oocytes donation * BMI \>35 * Uncontrolled Endocrine Pathology

Design outcomes

Primary

Measure	Time frame
Pregnancy rate	six weeks after transfer procedure

Secondary

Measure	Time frame
Number of Mature oocytes	Day of oocyte retrieval

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026